How to research a manufacturer across FDA names
Check applicant and recalling-firm names without confusing spelling variations, subsidiaries, and unrelated companies.
Read the guide →Medical-device intelligence
Research Ark Diagnostics, Inc. in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.
This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.
16 clearance records and 0 recall records in the covered releases, across 1 source company names and 8 product codes. Dated history runs from Apr 16, 2009 to Feb 27, 2024.
| Month | 510(k) decisions | Recall initiations |
|---|---|---|
| October 2025 | 0 | 0 |
| November 2025 | 0 | 0 |
| December 2025 | 0 | 0 |
| January 2026 | 0 | 0 |
| February 2026 | 0 | 0 |
| March 2026 | 0 | 0 |
| April 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| June 2026 | 0 | 0 |
| July 2026 | 0 | 0 |
| August 2026 | 0 | 0 |
| September 2026 | 0 | 0 |
| October 2026 | 0 | 0 |
| Device / record | Company in FDA record | Source | Source date |
|---|---|---|---|
| ARK Levetiracetam II AssayK232522 · ORI | Ark Diagnostics, Inc. | 510(k) | Feb 27, 2024FDA decision date |
| ARK Methotrexate II AssayK232017 · LAO | Ark Diagnostics, Inc. | 510(k) | Dec 20, 2023FDA decision date |
| ARK Hydrocodone AssayK231752 · DJG | Ark Diagnostics, Inc. | 510(k) | Nov 9, 2023FDA decision date |
| ARK Lacosamide AssayK201089 · NWM | Ark Diagnostics, Inc. | 510(k) | Aug 5, 2021FDA decision date |
| ARK Fentanyl II AssayK200197 · DJG | Ark Diagnostics, Inc. | 510(k) | Feb 26, 2020FDA decision date |
| ARK Tramadol AssayK182280 · DJG | Ark Diagnostics, Inc. | 510(k) | Dec 10, 2018FDA decision date |
| ARK EDDP AssayK182779 · DJR | Ark Diagnostics, Inc. | 510(k) | Nov 21, 2018FDA decision date |
| ARK Fentanyl AssayK180427 · DJG | Ark Diagnostics, Inc. | 510(k) | Jun 6, 2018FDA decision date |
| ARK Methotrexate AssayK163359 · LAO | Ark Diagnostics, Inc. | 510(k) | Aug 18, 2017FDA decision date |
| ARK Oxcarbazepine Metabolite Assay, ARK Oxcarbazepine Metabolite Calibrator, ARK Oxcarbazepine Metabolite ControlK153596 · POX | Ark Diagnostics, Inc. | 510(k) | Aug 9, 2016FDA decision date |
| ARK METHOTREXATE ASSAY, ARK METHOTREXATE CALIBRATOR, ARK METHOTREXATE CONTROL, ARK METHOTREXATE CONTROL (CALIBRATION RANK111904 · LAO | Ark Diagnostics, Inc. | 510(k) | Oct 18, 2011FDA decision date |
| ARK GABAPENTIN ASSAY, ARK GABEPENTIN CALIFRATOR, AND ARK GABAPENTIN CONTROL MODEL5025-0001-00, 5025-0002-00, 5025-0003-0K101574 · OTF | Ark Diagnostics, Inc. | 510(k) | Nov 23, 2010FDA decision date |
| ARK LAMOTRIGINE ASSAY, CALIBRATOR & CONTROLK101305 · ORH | Ark Diagnostics, Inc. | 510(k) | Oct 29, 2010FDA decision date |
| ARK ZONISAMIDE ASSAY, ARK ZONISAMIDE CALIBRATOR, AND ARK ZONISAMIDE CONTRO, MODELS 5022-0001-00, 5022-0002-00, 5022-0003K091884 · NWM | Ark Diagnostics, Inc. | 510(k) | Dec 9, 2009FDA decision date |
| ARK LEVETIRACETAM ASSAY, ARK LEVETIRACETAM CALIBRATOR AND ARK LEVETIRACETAM CONTROL, MODELS 5024-0001-00, 5024-0002-00K091653 · ORI | Ark Diagnostics, Inc. | 510(k) | Nov 2, 2009FDA decision date |
| TOPIRAMATE ASSAY, ARK TOPIRAMATE CALIBRATOR AND ARK TOPIRAMATE CONTROL, MODELS 5015-0001-000, 5015-0002-00, 5015-0003-00K083799 · NWM | Ark Diagnostics, Inc. | 510(k) | Apr 16, 2009FDA decision date |
Check applicant and recalling-firm names without confusing spelling variations, subsidiaries, and unrelated companies.
Read the guide →Build a repeatable clearance search using FDA applicant names, product codes, decision dates, and original records.
Read the guide →FDA dataset:
Last successful check: Nov 22, 2026
Source classifications may change.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset monthly.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset weekly.
Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.